• Home>
  • Stocks>
  • Caplin Point Laboratories Ltd Share Price
Caplin Point Laboratories Ltd share price logo

Caplin Point Laboratories Ltd Share Price (CAPLIPOINT)

₹2151.70.77%

as on

| Source : NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Caplin Point Laboratories Ltd Stock Performance

as on August 18, 2025 at 4:01 PM IST

  • Day's Low

    Day's High

    ₹2,110.7
    ₹2,157.3
    downward going graph

    1.91%

    Downside

    0.26%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹1,535
    ₹2,641
    downward going graph

    28.66%

    Downside

    22.74%

    Upside

    downward going graph
Previous Close₹2,135.20
Open₹2,150.90
Volume71.75K
Upper Circuit₹2,562.20
Lower Circuit₹1,708.20
Day's Low2,110.7
Day's High2,157.3
52 Week Low1,535
52 Week High2,641
1 Month Return+ 1.52 %
3 Month Return-1.2 %
1 Year Return+ 15.67 %
3 Year Return+ 168.14 %
5 Year Return+ 292.97 %

Caplin Point Laboratories Ltd Stock Fundamentals & Key Indicators

Check Caplin Point Laboratories Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹16,230.02 Cr

Return on Equity (ROE)

22.43

PE Ratio (TTM)

28.72

Return on capital employed (ROCE)

28.84

Industry PE ratio

43.28

Beta (LTM)

1.47

P/B Ratio

7.2

Dividend Yield

0.38

PEG Ratio

2.51

Quarterly Earnings Growth YOY

20.69

EPS (TTM)

60.75

Sector

Pharmaceuticals

Book Value

276.38

Technical Analysis

Caplin Point Laboratories Ltd Stock's Interest Amongst Investors

-6%

Period Aug 19, 2025 to Jul 20, 2025. Change in 30 Days vs previous period

Search interest for Caplin Point Laboratories Ltd Stock has decreased by -6% in the last 30 days, reflecting a downward trend in search activity.

Caplin Point Laboratories Ltd Stock Valuation

Track how Caplin Point Laboratories Ltd P/E has moved over time to understand its valuation trends.

Caplin Point Laboratories Ltd in the last 5 years

  • Overview

  • Trends

Lowest (6.76x)

March 24, 2020

Today (28.72x)

August 14, 2025

Industry (43.28x)

August 14, 2025

Highest (40.01x)

December 27, 2024

LowHigh

Today’s Price to Earnings Ratio: 28.72x

Caplin Point Laboratories Ltd Stock Recommendation

Get updated buy, sell, and hold recommendations by analysts on Caplin Point Laboratories Ltd.

based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

100% of analysts recommend a 'BUY' rating for Caplin Point Laboratories Ltd. Average target price of ₹2508

Source: S&P Global Market Intelligence

Caplin Point Laboratories Ltd Share Price Target

Get share price movements and forecasts by analysts on Caplin Point Laboratories Ltd.

Caplin Point Laboratories Ltd price forecast by 2 analysts

Upside of17.46%

High

₹2516

Target

₹2508.00

Low

₹2500

Caplin Point Laboratories Ltd target price ₹2508, a slight upside of 17.46% compared to current price of ₹2151.7. According to 2 analysts rating.

Source: S&P Global Market Intelligence

Caplin Point Laboratories Ltd Financial Results

Get the annual and quarterly financial summary of Caplin Point Laboratories Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26
Revenue

(in ₹ Cr)

459 (0%)483 (5%)493 (2%)502 (2%)510 (2%)
Net Income

(in ₹ Cr)

125 (0%)131 (5%)140 (7%)145 (4%)151 (4%)
Net Profit Margin27.22% (0%)27.08% (1%)28.41% (5%)28.91% (2%)29.55% (2%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

1383 (0%)1758 (27%)2206 (25%)2707 (23%)
Total Liabilities

(in ₹ Cr)

198 (0%)274 (39%)325 (19%)391 (20%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

87 (0%)295 (239%)231 (22%)157 (32%)111 (29%)

Caplin Point Laboratories Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Caplin Point Laboratories Ltd.

  • Caplin Point Laboratories Ltd Earnings Results

    Caplin Point Laboratories Ltd’s net profit jumped 23.26% since last year same period to ₹152.80Cr in the Q1 2025-2026. On a quarterly growth basis, Caplin Point Laboratories Ltd has generated 7.18% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Caplin Point Laboratories Ltd Dividends May,2025

    In the quarter ending March 2025, Caplin Point Laboratories Ltd has declared dividend of ₹3.00 per share on 15 May 2025 - translating a dividend yield of 0.37%.

    Read More about Dividends

Indices Featuring Caplin Point Laboratories Ltd Stock

Check stock indices that include Caplin Point Laboratories Ltd.

Nifty Smallcap 250

₹16,878.70

1.33 (221.95%)

Nifty MidSmallcap 400

₹19,695.40

1.24 (241.2%)

S&P BSE 400 MidSmallCap

₹11,896.71

1.33 (155.64%)

BSE 500

₹36,001.36

1.11 (396.87%)

BSE Healthcare

₹44,542.10

0.2 (88.75%)

Nifty 500

₹22,931.50

1.11 (251.25%)

S&P BSE 250 SmallCap

₹6,758.20

1.37 (91.04%)

BSE Small-Cap

₹52,510.54

1.39 (721.66%)

Caplin Point Laboratories Ltd Stock Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Caplin Point Laboratories Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
70.56%
0.00
Foreign Institutions
6.14%
7.63
Mutual Funds
1.93%
10.82
Retail Investors
21.05%
-3.00
Others
0.32%
9.47

Caplin Point Laboratories Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Caplin Point Laboratories Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
BUY16,230.0258.59%0.514611,694
BUY34,960.9035.99%0.523001,051
BUY16,822.089.72%0.718367,234
NA4,551.09-4.22%1.88-34371
BUY15,765.9048.97%0.672441,515

Caplin Point Laboratories Ltd News & Key Events

Latest news and events in one place to help you make informed investing decisions in Caplin Point Laboratories Ltd.

  • Caplin Point Reports Strong Q1 Results and Dividend - 07 Aug, 2025

    Caplin Point Laboratories announced a final dividend of Rs 3 per share and reported strong Q1 FY26 results, with net profit rising 23.2% YoY. Shares surged 6% following the announcement. The record date for the dividend is set for September 12, 2025.

Insights on Caplin Point Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, CAPLIPOINT has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 5.70% to 6.14% in Jun 2025 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 20 quarters, 269.88 Cr → 533.39 Cr (in ₹), with an average increase of 3.5% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 15 quarters, 74.95 Cr → 152.8 Cr (in ₹), with an average increase of 4.9% per quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 1.74% to 1.93% in Jun 2025 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, CAPLIPOINT stock has moved up by 1.3%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 70.56% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 31.3% return, outperforming this stock by 15.7%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 21.70% to 21.05% in Jun 2025 quarter

About Caplin Point Laboratories Ltd

Caplin Point Laboratories Limited was founded in the year 1990 and is a fully integrated transnational pharmaceutical company. With over 4000 product registrations covering 36 therapeutic segments, the company has set up its presence in 23 countries. It specializes in producing and marketing of wide range of generic formulations and branded products and exporting them to markets like the US, European Union, Africa, LATAM and others. The company has also established a trading branch in Nairobi Kenya and a warehouse in Miami USA in collaboration with Lockett Corp. It completed splitting its shares in 2016 from Rs. 10 to Rs. 2 each. As on date, the company has three subsidiaries in India, Hong Kong and Colombia. It invested in Argus Salud Pharma LLP and set up a Joint venture in China. It also ventured into the ecommerce space. In the year 2021, the company has already received four ANDA approvals and 8 product launches. It has planned to file more 18 ANDAs with an addressable market size of USD 1.95 billion and is investing a sum of Rs. 140 crores in setting up its second Injectable Plant with 2 Vial lines, a Lyophilizer line and a Pre filled syringe line.

Revenue: ₹510.22Cr as on June 2025 (Q1 FY26)
Net Profit: ₹150.76Cr as on June 2025 (Q1 FY26)
Listing date: 23 Jun, 2014
Chairperson Name: C C Paarthipan
OrganisationCaplin Point Laboratories Ltd
HeadquartersChennai
IndustryPharmaceuticals
CEOC C Paarthipan
E-voting on sharesClick here to vote

Mutual Funds that own Caplin Point Laboratories Ltd Stock

Check out the Mutual Funds with significant holdings in Caplin Point Laboratories Ltd.

FAQs

What is Caplin Point Laboratories Ltd share price today?

Caplin Point Laboratories Ltd share price today stands at ₹2151.7, Open: ₹2150.9, Previous Close: ₹2135.2, High: ₹2157.3, Low: ₹2110.7, 52 Week High: ₹2641, 52 Week Low: ₹1535 as on .

How to buy Caplin Point Laboratories Ltd shares ?

To buy Caplin Point Laboratories Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for CAPLIPOINT or Caplin Point Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Caplin Point Laboratories Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is today's traded volume of Caplin Point Laboratories Ltd?

Today's traded volume of Caplin Point Laboratories Ltd is 71.75K. Which means that 71.75K shares of Caplin Point Laboratories Ltd were bought and sold on the stock market during today's trading session.

What is Caplin Point Laboratories Ltd's market cap today?

Today's market capitalisation of Caplin Point Laboratories Ltd is ₹16,230.02 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Caplin Point Laboratories Ltd?

Caplin Point Laboratories Ltd’s 52 week high is ₹2641 and 52 week low is ₹1535. The current share price of Caplin Point Laboratories Ltd is ₹2151.7, which is -18.53% down from its 52 week high and 40.18% up from its 52 week low.